Interest of Self-compression Technique on Tolerance of Mammography (ITACTs)

August 7, 2018 updated by: Institut de Cancérologie de Lorraine

Mammography is used for screening, diagnosis, therapeutic evaluation and monitoring of local cancer breast.

It is sometimes poorly tolerated by some patients who complain of an uncomfortable examination or pain.

Breast compression by the manipulator aims to reduce the thickness of the breast during mammography; This act is an important factor of pain or discomfort felt by the patient. But, it is also an image quality factor.

This study aimed to compare self-breast compression by the patient to the compression standard technique carried out by the manipulator.

Study Overview

Study Type

Interventional

Enrollment (Actual)

550

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France, 33000
        • Institut Bergonie
      • Caen, France, 14076
        • Centre Francois Baclesse
      • Nancy, France, 54000
        • Cabinet de Radiologie
      • Nancy, France, 54000
        • Polyclinique Majorelle
      • Paris, France, 75248
        • Institut Curie
      • Vandoeuvre-les-Nancy, France, 54519
        • Institut de Cancérologie de Lorraine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Adult patients ≥ 18 years and ≤ 75 years of age
  • ECOG performance <2
  • Mammography planned as part of a breast cancer screening or a monitoring following treatment of a breast lesion
  • Ability to provide written informed consent
  • Patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study.

Exclusion Criteria:

  • Eastern Cooperative Oncology Group performance status ≥ 2
  • Treatment for benign lesion with surgery for less than 3 years
  • Treatment for cancer with surgery and / or radiotherapy for less than 3 years
  • Biopsy for less than 1 year
  • Breast prosthesis
  • Mastectomy
  • Assessment motivated by a clinical breast abnormality

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm A
Patients have a mammography performed by themselves according to auto-compression procedure. The radiologist leads the compression at a minimum threshold of 40 Newton, then leaves the control of the compression to the patient. The radiologist treats only the positioning of the breast on the sensor.
Active Comparator: Arm B
Patients have a mammography performed by the radiologist according to standard procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of two breast compression techniques (auto-compression versus standard procedure) in mammography
Time Frame: 1 day
The comparison will be evaluated by the thickness (mm) of breast compressed
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall tolerance of mammography
Time Frame: 1 day
The overall tolerance of mammography will be assessed by the patient after 4 shots. The pain felt by the patient will be assessed using a visual analog scale.
1 day
Breast compression force
Time Frame: 1 day
Value measured on compressive force console (Newtons)
1 day
Thickness / compressing force ratio
Time Frame: 1 day
1 day
Image quality
Time Frame: 1 day
The image quality will be assessed by the radiologist with a quotation of motion blurring on a 4-point scale
1 day
Overall assessment of the manipulator
Time Frame: 1 day
The appreciation of the manipulator will be assessed using a 4-point scale
1 day
Overall assessment of self-satisfaction of the patient at the end of the examination
Time Frame: 1 day
The measurement of patient satisfaction will be evaluated using a self-administered Norwegian questionnaire (MammoGraphy Questionnaire)
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: HENROT Philippe, MD, Institut de Cancérologie de Lorraine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

August 10, 2016

First Submitted That Met QC Criteria

August 10, 2016

First Posted (Estimate)

August 15, 2016

Study Record Updates

Last Update Posted (Actual)

August 8, 2018

Last Update Submitted That Met QC Criteria

August 7, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2012-A00248-35

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on mammography according to an auto-compression procedure

Subscribe